206 related articles for article (PubMed ID: 35359938)
1. Single-Cell Multiomics Reveals Clonal T-Cell Expansions and Exhaustion in Blastic Plasmacytoid Dendritic Cell Neoplasm.
DePasquale EAK; Ssozi D; Ainciburu M; Good J; Noel J; Villanueva MA; Couturier CP; Shalek AK; Aranki SF; Mallidi HR; Griffin GK; Lane AA; van Galen P
Front Immunol; 2022; 13():809414. PubMed ID: 35359938
[TBL] [Abstract][Full Text] [Related]
2. Early T-cell precursor lymphoblastic leukemia accompanied by prominent blastic plasmacytoid dendritic cell proliferation mimicking blastic plasmacytoid dendritic cell neoplasm: an exceptional case report and literature review.
Liao H; Yu J; Liu Y; Zhao S; Zhu H; Xu D; Jiang N; Zheng Q
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2911-2919. PubMed ID: 35933443
[TBL] [Abstract][Full Text] [Related]
3. E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell Neoplasm.
Lorenzi L; Lonardi S; Vairo D; Bernardelli A; Tomaselli M; Bugatti M; Licini S; Arisi M; Cerroni L; Tucci A; Vermi W; Giliani SC; Facchetti F
Am J Surg Pathol; 2021 Oct; 45(10):1428-1438. PubMed ID: 34081040
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive metagenomic analysis of blastic plasmacytoid dendritic cell neoplasm.
Nomburg J; Bullman S; Chung SS; Togami K; Walker MA; Griffin GK; Morgan EA; LeBoeuf NR; DeCaprio JA; Meyerson M; Lane AA
Blood Adv; 2020 Mar; 4(6):1006-1011. PubMed ID: 32182365
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis.
Renosi F; Roggy A; Giguelay A; Soret L; Viailly PJ; Cheok M; Biichle S; Angelot-Delettre F; Asnafi V; Macintyre E; Geffroy S; Callanan M; Petrella T; Deconinck E; Daguindau E; Harrivel V; Bouyer S; Salaun V; Saussoy P; Feuillard J; Fuseau P; Saas P; Adotévi O; Jardin F; Ferrand C; Preudhomme C; Colinge J; Roumier C; Garnache-Ottou F
Blood Adv; 2021 Mar; 5(5):1540-1551. PubMed ID: 33687433
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients.
Khanlari M; Yin CC; Takahashi K; Lachowiez C; Tang G; Loghavi S; Bah I; Wang W; Konoplev S; Medeiros LJ; Pemmaraju N; Khoury JD; Wang SA
Leukemia; 2022 May; 36(5):1343-1350. PubMed ID: 35279700
[TBL] [Abstract][Full Text] [Related]
7. Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms.
Small C; Mukerjee S; Jangam D; Gollapudi S; Singh K; Jaye DL; Aung PP; Querfeld C; Yao K; Chisholm KM; Pullarkat S; Wang S; Gru A; Hussaini M; George TI; Ohgami RS
Int J Lab Hematol; 2023 Oct; 45(5):726-734. PubMed ID: 37282364
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid dendritic cell neoplasms.
Lee YJ; Kim Y; Park SH; Jo JC
Blood Res; 2023 Apr; 58(S1):90-95. PubMed ID: 37105563
[TBL] [Abstract][Full Text] [Related]
9. Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.
Sapienza MR; Pileri S
Hematol Oncol Clin North Am; 2020 Jun; 34(3):511-521. PubMed ID: 32336416
[TBL] [Abstract][Full Text] [Related]
10. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
Paluri R; Nabell L; Borak S; Peker D
Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.
Wang W; Khoury JD; Miranda RN; Jorgensen JL; Xu J; Loghavi S; Li S; Pemmaraju N; Nguyen T; Medeiros LJ; Wang SA
Haematologica; 2021 Apr; 106(4):1047-1055. PubMed ID: 32241840
[TBL] [Abstract][Full Text] [Related]
12. [Enhancer hijacking via disease-specific chromosomal translocation in blastic plasmacytoid dendritic cell neoplasm].
Kubota S
Rinsho Ketsueki; 2020; 61(1):47-51. PubMed ID: 32023603
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm.
Wang W; Xu J; Khoury JD; Pemmaraju N; Fang H; Miranda RN; Yin CC; Hussein SE; Jia F; Tang Z; Hu S; Konopleva M; Medeiros LJ; Wang SA
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884435
[TBL] [Abstract][Full Text] [Related]
14. Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells.
Cai T; Gouble A; Black KL; Skwarska A; Naqvi AS; Taylor D; Zhao M; Yuan Q; Sugita M; Zhang Q; Galetto R; Filipe S; Cavazos A; Han L; Kuruvilla V; Ma H; Weng C; Liu CG; Liu X; Konoplev S; Gu J; Tang G; Su X; Al-Atrash G; Ciurea S; Neelapu SS; Lane AA; Kantarjian H; Guzman ML; Pemmaraju N; Smith J; Thomas-Tikhonenko A; Konopleva M
Nat Commun; 2022 Apr; 13(1):2228. PubMed ID: 35484100
[TBL] [Abstract][Full Text] [Related]
15. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms.
El Hussein S; Yabe M; Wang W; Pemmaraju N; Loghavi S; Jelloul FZ; Fang H; Medeiros LJ; Burack WR; Evans AG; Liesveld JL; Bennett JM
EJHaem; 2022 Aug; 3(3):954-957. PubMed ID: 36051075
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of 46 cases with CD4
Suzuki Y; Kato S; Kohno K; Satou A; Eladl AE; Asano N; Kono M; Kato Y; Taniwaki M; Akiyama M; Nakamura S
Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410
[TBL] [Abstract][Full Text] [Related]
17. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.
Cheng W; Yu TT; Tang AP; He Young K; Yu L
Curr Med Sci; 2021 Jun; 41(3):405-419. PubMed ID: 34218354
[TBL] [Abstract][Full Text] [Related]
18. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
Lim MS; Lemmert K; Enjeti A
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
[TBL] [Abstract][Full Text] [Related]
19. Plasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms.
Roussel X; Garnache Ottou F; Renosi F
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884612
[TBL] [Abstract][Full Text] [Related]
20. Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective.
Hirner JP; O'Malley JT; LeBoeuf NR
Hematol Oncol Clin North Am; 2020 Jun; 34(3):501-509. PubMed ID: 32336415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
